University of Illinois at Chicago Clinical Research Center

Chicago, Illinois 60612

1 studies enrolling now · 8 studies all time

What they study most

Anemia, Sickle Cell, Healthy, Moderate-severe Pain, Phase 1 Sickle Cell, Sickle Cell Anemia, Sickle Cell Disease

Studies at this site

• A Phase 2/3 Study in Adult and Adolescent Participants With SCD — Recruiting now
• Dose Escalation Study of PF-07209326 in Healthy Participants and Participants With Sickle Cell Disease — Completed
• Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031 — Stopped early
• Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease — Stopped early
• Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease — Completed
• Safety and Pharmacokinetic Study of EMBEDA in Children Ages 7-17 With Pain — Stopped early
• Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With Pain — Stopped early
• Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Study Of PF-04447943, Co-Administered With And Without Hydroxyurea, In Subjects With Stable Sickle Cell Disease — Completed